Concepts (359)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tandem Mass Spectrometry | 21 | 2019 | 57 | 2.140 |
Why?
|
| Environmental Exposure | 11 | 2015 | 87 | 1.490 |
Why?
|
| Chromatography, High Pressure Liquid | 14 | 2019 | 93 | 1.340 |
Why?
|
| Cotinine | 7 | 2018 | 45 | 1.230 |
Why?
|
| Smoking | 7 | 2018 | 439 | 1.150 |
Why?
|
| Trans Fatty Acids | 2 | 2017 | 10 | 1.030 |
Why?
|
| Nutritional Status | 2 | 2017 | 68 | 1.020 |
Why?
|
| Environmental Monitoring | 10 | 2014 | 26 | 0.910 |
Why?
|
| Nutrition Surveys | 7 | 2017 | 136 | 0.910 |
Why?
|
| Botulinum Toxins | 9 | 2012 | 37 | 0.860 |
Why?
|
| United States | 26 | 2018 | 3648 | 0.810 |
Why?
|
| Chromatography, Liquid | 11 | 2018 | 42 | 0.750 |
Why?
|
| Creatinine | 4 | 2010 | 174 | 0.700 |
Why?
|
| Glucuronides | 1 | 2018 | 2 | 0.660 |
Why?
|
| Hypoglycins | 5 | 2018 | 5 | 0.650 |
Why?
|
| Glycine | 5 | 2018 | 25 | 0.640 |
Why?
|
| Cyclopropanes | 5 | 2018 | 20 | 0.640 |
Why?
|
| Nicotine | 2 | 2018 | 158 | 0.630 |
Why?
|
| Tobacco Smoke Pollution | 5 | 2010 | 37 | 0.630 |
Why?
|
| Humans | 57 | 2019 | 29241 | 0.620 |
Why?
|
| Ultrafiltration | 1 | 2017 | 9 | 0.610 |
Why?
|
| Adult | 25 | 2017 | 8469 | 0.610 |
Why?
|
| Nitrosamines | 4 | 2010 | 10 | 0.610 |
Why?
|
| Hypotension | 1 | 2017 | 47 | 0.590 |
Why?
|
| Fasting | 1 | 2017 | 93 | 0.580 |
Why?
|
| Dietary Fats | 1 | 2017 | 108 | 0.570 |
Why?
|
| Diet | 3 | 2017 | 356 | 0.570 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 9 | 2012 | 27 | 0.560 |
Why?
|
| Mass Spectrometry | 9 | 2017 | 100 | 0.550 |
Why?
|
| Hyperkalemia | 1 | 2015 | 11 | 0.540 |
Why?
|
| Pyridines | 3 | 2010 | 78 | 0.540 |
Why?
|
| Hypoglycemia | 1 | 2015 | 41 | 0.530 |
Why?
|
| Female | 30 | 2017 | 18242 | 0.530 |
Why?
|
| Middle Aged | 18 | 2017 | 10872 | 0.520 |
Why?
|
| Hematinics | 1 | 2014 | 5 | 0.510 |
Why?
|
| Environmental Pollutants | 4 | 2014 | 19 | 0.510 |
Why?
|
| Organic Chemicals | 2 | 2011 | 7 | 0.510 |
Why?
|
| Solid Phase Extraction | 4 | 2014 | 4 | 0.500 |
Why?
|
| Peritoneal Dialysis | 1 | 2014 | 22 | 0.500 |
Why?
|
| Renal Dialysis | 1 | 2017 | 261 | 0.500 |
Why?
|
| Glucose | 1 | 2015 | 164 | 0.500 |
Why?
|
| Anemia | 1 | 2014 | 55 | 0.490 |
Why?
|
| Sodium Chloride, Dietary | 1 | 2014 | 29 | 0.480 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 5 | 2011 | 5 | 0.470 |
Why?
|
| Urinalysis | 2 | 2012 | 19 | 0.460 |
Why?
|
| Insulin | 1 | 2015 | 346 | 0.460 |
Why?
|
| Immune Complex Diseases | 1 | 2013 | 2 | 0.460 |
Why?
|
| Antibodies, Antinuclear | 1 | 2013 | 18 | 0.460 |
Why?
|
| Kidney Failure, Chronic | 2 | 2015 | 519 | 0.450 |
Why?
|
| Male | 26 | 2017 | 17877 | 0.450 |
Why?
|
| Hematuria | 1 | 2012 | 7 | 0.450 |
Why?
|
| Lupus Nephritis | 1 | 2013 | 30 | 0.450 |
Why?
|
| Lactobacillus | 1 | 2012 | 8 | 0.450 |
Why?
|
| Patient Compliance | 1 | 2014 | 212 | 0.440 |
Why?
|
| European Continental Ancestry Group | 4 | 2012 | 1131 | 0.440 |
Why?
|
| Endopeptidases | 5 | 2012 | 27 | 0.430 |
Why?
|
| Young Adult | 7 | 2017 | 2413 | 0.400 |
Why?
|
| Adolescent | 16 | 2017 | 3267 | 0.390 |
Why?
|
| Amino Acid Sequence | 16 | 2017 | 283 | 0.380 |
Why?
|
| Aged | 11 | 2017 | 9515 | 0.350 |
Why?
|
| Proteomics | 5 | 2016 | 92 | 0.350 |
Why?
|
| Child | 13 | 2017 | 2225 | 0.340 |
Why?
|
| Antigens, Bacterial | 4 | 2011 | 18 | 0.340 |
Why?
|
| Reproducibility of Results | 8 | 2019 | 726 | 0.340 |
Why?
|
| Trypsin | 4 | 2017 | 12 | 0.340 |
Why?
|
| Cataract | 1 | 2008 | 5 | 0.330 |
Why?
|
| Carcinogens | 5 | 2010 | 34 | 0.330 |
Why?
|
| Blood Chemical Analysis | 5 | 2018 | 21 | 0.330 |
Why?
|
| Fruit | 3 | 2018 | 53 | 0.330 |
Why?
|
| Macular Degeneration | 1 | 2008 | 21 | 0.330 |
Why?
|
| Zinc | 1 | 2008 | 32 | 0.330 |
Why?
|
| Data Interpretation, Statistical | 1 | 2008 | 105 | 0.320 |
Why?
|
| Antioxidants | 1 | 2008 | 114 | 0.310 |
Why?
|
| Influenza Vaccines | 4 | 2014 | 78 | 0.300 |
Why?
|
| Viral Proteins | 3 | 2014 | 45 | 0.300 |
Why?
|
| Sapindus | 2 | 2018 | 2 | 0.300 |
Why?
|
| Hypertension | 1 | 2014 | 913 | 0.300 |
Why?
|
| Molecular Sequence Data | 13 | 2014 | 354 | 0.290 |
Why?
|
| Ricin | 3 | 2011 | 4 | 0.290 |
Why?
|
| Antibodies, Monoclonal | 4 | 2011 | 197 | 0.270 |
Why?
|
| Bacterial Toxins | 3 | 2011 | 16 | 0.270 |
Why?
|
| Public Health | 2 | 2011 | 73 | 0.260 |
Why?
|
| Apolipoproteins | 2 | 2018 | 196 | 0.260 |
Why?
|
| Information Services | 1 | 2005 | 10 | 0.260 |
Why?
|
| Reference Values | 5 | 2013 | 224 | 0.260 |
Why?
|
| Maternal Exposure | 1 | 2004 | 10 | 0.260 |
Why?
|
| Peptides | 6 | 2012 | 118 | 0.250 |
Why?
|
| Pregnancy Outcome | 1 | 2004 | 52 | 0.250 |
Why?
|
| Age Factors | 7 | 2013 | 1112 | 0.240 |
Why?
|
| Retrospective Studies | 3 | 2017 | 3122 | 0.240 |
Why?
|
| Sex Factors | 5 | 2013 | 632 | 0.230 |
Why?
|
| Tobacco | 3 | 2010 | 50 | 0.230 |
Why?
|
| Disease Outbreaks | 2 | 2017 | 35 | 0.230 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 3 | 2017 | 26 | 0.230 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2017 | 17 | 0.210 |
Why?
|
| Vesicle-Associated Membrane Protein 2 | 2 | 2011 | 2 | 0.200 |
Why?
|
| Sensitivity and Specificity | 5 | 2019 | 533 | 0.200 |
Why?
|
| Hemoglobins | 2 | 2014 | 42 | 0.190 |
Why?
|
| Apolipoprotein B-100 | 2 | 2018 | 10 | 0.190 |
Why?
|
| Apolipoprotein A-I | 2 | 2018 | 68 | 0.190 |
Why?
|
| Sapindaceae | 2 | 2018 | 2 | 0.190 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2011 | 34 | 0.190 |
Why?
|
| Reverse Transcriptase Inhibitors | 2 | 2009 | 6 | 0.180 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 2 | 2009 | 3 | 0.180 |
Why?
|
| Neurotoxins | 2 | 2012 | 16 | 0.180 |
Why?
|
| Insecticides | 3 | 2004 | 21 | 0.170 |
Why?
|
| Cholesterol | 2 | 2018 | 230 | 0.170 |
Why?
|
| Phospholipids | 1 | 2019 | 27 | 0.170 |
Why?
|
| Asthma | 1 | 2002 | 397 | 0.170 |
Why?
|
| African Continental Ancestry Group | 3 | 2010 | 350 | 0.170 |
Why?
|
| Dyslipidemias | 1 | 2019 | 52 | 0.170 |
Why?
|
| Anthrax | 2 | 2009 | 5 | 0.160 |
Why?
|
| Fractionation, Field Flow | 1 | 2018 | 1 | 0.160 |
Why?
|
| Lipids | 2 | 2018 | 211 | 0.160 |
Why?
|
| Lipoproteins | 1 | 2018 | 82 | 0.160 |
Why?
|
| Botulism | 3 | 2012 | 9 | 0.150 |
Why?
|
| Hydrogenation | 1 | 2017 | 1 | 0.150 |
Why?
|
| Litchi | 1 | 2017 | 1 | 0.150 |
Why?
|
| Isotope Labeling | 3 | 2011 | 17 | 0.150 |
Why?
|
| Aged, 80 and over | 2 | 2017 | 3728 | 0.150 |
Why?
|
| Smoke | 2 | 2009 | 12 | 0.150 |
Why?
|
| Triglycerides | 1 | 2017 | 214 | 0.140 |
Why?
|
| Influenza A virus | 2 | 2014 | 21 | 0.140 |
Why?
|
| Occupational Exposure | 3 | 2004 | 224 | 0.140 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 788 | 0.140 |
Why?
|
| Quality Control | 3 | 2018 | 38 | 0.140 |
Why?
|
| Feeding Behavior | 1 | 2017 | 159 | 0.140 |
Why?
|
| Clostridium botulinum | 2 | 2012 | 3 | 0.130 |
Why?
|
| Pregnancy | 3 | 2014 | 816 | 0.130 |
Why?
|
| Prevalence | 1 | 2018 | 907 | 0.130 |
Why?
|
| Child, Preschool | 5 | 2009 | 1170 | 0.130 |
Why?
|
| Ethnic Groups | 4 | 2013 | 440 | 0.130 |
Why?
|
| Sex Distribution | 2 | 2014 | 186 | 0.130 |
Why?
|
| Linear Models | 3 | 2018 | 427 | 0.130 |
Why?
|
| Neuraminidase | 2 | 2011 | 10 | 0.130 |
Why?
|
| Cross-Sectional Studies | 4 | 2014 | 1366 | 0.130 |
Why?
|
| Erythropoietin | 1 | 2014 | 29 | 0.130 |
Why?
|
| Glomerular Filtration Rate | 1 | 2015 | 287 | 0.120 |
Why?
|
| Influenza in Birds | 1 | 2014 | 3 | 0.120 |
Why?
|
| Animals | 12 | 2015 | 7309 | 0.120 |
Why?
|
| Incidence | 2 | 2015 | 1123 | 0.120 |
Why?
|
| Substrate Specificity | 5 | 2012 | 84 | 0.120 |
Why?
|
| Phenols | 1 | 2014 | 16 | 0.120 |
Why?
|
| Peptide Fragments | 1 | 2017 | 423 | 0.120 |
Why?
|
| California | 2 | 2004 | 60 | 0.120 |
Why?
|
| Child Development | 1 | 2014 | 35 | 0.120 |
Why?
|
| Calibration | 4 | 2018 | 25 | 0.120 |
Why?
|
| Health Surveys | 1 | 2014 | 191 | 0.120 |
Why?
|
| Trace Elements | 1 | 2013 | 7 | 0.120 |
Why?
|
| Bacterial Proteins | 2 | 2010 | 77 | 0.110 |
Why?
|
| Nutrition Policy | 1 | 2013 | 33 | 0.110 |
Why?
|
| Reagent Strips | 1 | 2012 | 4 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2017 | 1695 | 0.110 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2014 | 88 | 0.110 |
Why?
|
| False Positive Reactions | 1 | 2012 | 25 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2015 | 467 | 0.110 |
Why?
|
| Vitamins | 1 | 2013 | 59 | 0.110 |
Why?
|
| Atrazine | 1 | 2012 | 1 | 0.110 |
Why?
|
| Infant, Newborn | 2 | 2005 | 603 | 0.110 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 10 | 0.110 |
Why?
|
| Lead | 2 | 2009 | 6 | 0.100 |
Why?
|
| Follow-Up Studies | 3 | 2013 | 2114 | 0.100 |
Why?
|
| Beverages | 1 | 2011 | 19 | 0.100 |
Why?
|
| Castor Bean | 1 | 2011 | 1 | 0.100 |
Why?
|
| Toxicology | 1 | 2011 | 6 | 0.100 |
Why?
|
| Risk Factors | 2 | 2017 | 3550 | 0.100 |
Why?
|
| Plant Proteins | 1 | 2011 | 13 | 0.100 |
Why?
|
| Software | 1 | 2011 | 110 | 0.100 |
Why?
|
| Risk | 1 | 2012 | 290 | 0.100 |
Why?
|
| Immunoglobulin G | 2 | 2012 | 104 | 0.100 |
Why?
|
| Tars | 1 | 2010 | 2 | 0.100 |
Why?
|
| Clostridium | 1 | 2010 | 6 | 0.100 |
Why?
|
| Chemical Warfare Agents | 1 | 2011 | 13 | 0.100 |
Why?
|
| Polychlorinated Biphenyls | 3 | 2009 | 6 | 0.100 |
Why?
|
| Body Mass Index | 1 | 2014 | 867 | 0.100 |
Why?
|
| Plant Extracts | 1 | 2011 | 60 | 0.090 |
Why?
|
| Limit of Detection | 3 | 2018 | 15 | 0.090 |
Why?
|
| Polyphosphates | 1 | 2009 | 1 | 0.090 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2009 | 4 | 0.090 |
Why?
|
| Polyglutamic Acid | 1 | 2009 | 1 | 0.090 |
Why?
|
| Biochemistry | 1 | 2009 | 1 | 0.090 |
Why?
|
| Blood Pressure | 1 | 2014 | 807 | 0.090 |
Why?
|
| Nucleotides | 1 | 2009 | 16 | 0.090 |
Why?
|
| Nucleosides | 1 | 2009 | 10 | 0.090 |
Why?
|
| Lead Poisoning | 1 | 2009 | 3 | 0.090 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2009 | 66 | 0.090 |
Why?
|
| Socioeconomic Factors | 3 | 2006 | 394 | 0.090 |
Why?
|
| Air Pollution | 1 | 2009 | 17 | 0.090 |
Why?
|
| Air Pollutants | 1 | 2009 | 20 | 0.090 |
Why?
|
| Isotopes | 3 | 2017 | 11 | 0.080 |
Why?
|
| Conjunctivitis | 1 | 2008 | 3 | 0.080 |
Why?
|
| Micronutrients | 1 | 2008 | 15 | 0.080 |
Why?
|
| Complex Mixtures | 1 | 2008 | 3 | 0.080 |
Why?
|
| Antigens, Viral | 1 | 2008 | 19 | 0.080 |
Why?
|
| Pneumococcal Infections | 1 | 2008 | 30 | 0.080 |
Why?
|
| Streptococcus pneumoniae | 1 | 2008 | 40 | 0.080 |
Why?
|
| Orthomyxoviridae | 1 | 2008 | 14 | 0.080 |
Why?
|
| Infant | 3 | 2009 | 974 | 0.080 |
Why?
|
| Regression Analysis | 2 | 2005 | 274 | 0.080 |
Why?
|
| Anthrax Vaccines | 1 | 2007 | 4 | 0.080 |
Why?
|
| Thyroid Hormones | 1 | 2006 | 5 | 0.070 |
Why?
|
| Proteins | 1 | 2008 | 140 | 0.070 |
Why?
|
| Obesity | 1 | 2014 | 1068 | 0.070 |
Why?
|
| Disease Progression | 1 | 2008 | 572 | 0.070 |
Why?
|
| Mexican Americans | 1 | 2006 | 59 | 0.070 |
Why?
|
| Logistic Models | 2 | 2006 | 729 | 0.070 |
Why?
|
| Feces | 1 | 2006 | 29 | 0.070 |
Why?
|
| Milk | 1 | 2005 | 11 | 0.070 |
Why?
|
| Xenobiotics | 1 | 2005 | 1 | 0.070 |
Why?
|
| Population | 1 | 2005 | 8 | 0.070 |
Why?
|
| Nervous System | 1 | 2005 | 15 | 0.060 |
Why?
|
| Harm Reduction | 1 | 2004 | 11 | 0.060 |
Why?
|
| Fetal Death | 1 | 2004 | 6 | 0.060 |
Why?
|
| Maternal Age | 1 | 2004 | 8 | 0.060 |
Why?
|
| Community Health Centers | 1 | 2004 | 13 | 0.060 |
Why?
|
| Demography | 1 | 2005 | 104 | 0.060 |
Why?
|
| Pyrenes | 1 | 2004 | 1 | 0.060 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 1019 | 0.060 |
Why?
|
| Counseling | 1 | 2004 | 86 | 0.060 |
Why?
|
| Organothiophosphorus Compounds | 1 | 2004 | 7 | 0.060 |
Why?
|
| Macaca mulatta | 3 | 2011 | 322 | 0.060 |
Why?
|
| Behavior Therapy | 1 | 2004 | 92 | 0.060 |
Why?
|
| Air Pollutants, Occupational | 1 | 2003 | 4 | 0.060 |
Why?
|
| Terrorism | 1 | 2003 | 4 | 0.060 |
Why?
|
| Fires | 1 | 2003 | 4 | 0.060 |
Why?
|
| Selenium | 1 | 2003 | 3 | 0.060 |
Why?
|
| Methyl Parathion | 1 | 2002 | 1 | 0.060 |
Why?
|
| Nitrophenols | 1 | 2002 | 3 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 638 | 0.060 |
Why?
|
| Child Welfare | 1 | 2002 | 19 | 0.050 |
Why?
|
| Decision Making | 1 | 2005 | 180 | 0.050 |
Why?
|
| Reference Standards | 3 | 2009 | 30 | 0.050 |
Why?
|
| Health Status | 1 | 2005 | 369 | 0.050 |
Why?
|
| Health Education | 1 | 2002 | 121 | 0.050 |
Why?
|
| Parents | 1 | 2002 | 121 | 0.050 |
Why?
|
| Veterans | 1 | 2002 | 50 | 0.050 |
Why?
|
| Registries | 1 | 2002 | 280 | 0.050 |
Why?
|
| Smoking Cessation | 1 | 2002 | 133 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 2012 | 63 | 0.050 |
Why?
|
| Hispanic Americans | 2 | 2005 | 904 | 0.050 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 2 | 2011 | 22 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 173 | 0.040 |
Why?
|
| Age Distribution | 2 | 2010 | 198 | 0.040 |
Why?
|
| Plant Poisoning | 1 | 2018 | 1 | 0.040 |
Why?
|
| Inhalation | 2 | 2009 | 8 | 0.040 |
Why?
|
| Seeds | 1 | 2018 | 9 | 0.040 |
Why?
|
| Scattering, Radiation | 1 | 2018 | 7 | 0.040 |
Why?
|
| Mice | 3 | 2010 | 2375 | 0.040 |
Why?
|
| Workflow | 1 | 2018 | 20 | 0.040 |
Why?
|
| Particle Size | 1 | 2018 | 42 | 0.040 |
Why?
|
| Light | 1 | 2018 | 25 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2017 | 38 | 0.040 |
Why?
|
| Cholesterol Esters | 1 | 2017 | 37 | 0.040 |
Why?
|
| Hydrocarbons, Chlorinated | 2 | 2009 | 4 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2018 | 164 | 0.040 |
Why?
|
| India | 1 | 2017 | 61 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2016 | 18 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2016 | 267 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2017 | 448 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 862 | 0.030 |
Why?
|
| Pesticides | 2 | 2009 | 189 | 0.030 |
Why?
|
| Birds | 1 | 2014 | 4 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2014 | 73 | 0.030 |
Why?
|
| Financing, Government | 1 | 2014 | 10 | 0.030 |
Why?
|
| Acetylation | 1 | 2012 | 13 | 0.030 |
Why?
|
| Drug Stability | 1 | 2012 | 8 | 0.030 |
Why?
|
| Guanidine | 1 | 2012 | 3 | 0.030 |
Why?
|
| Gels | 1 | 2012 | 33 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2014 | 478 | 0.030 |
Why?
|
| Epitope Mapping | 1 | 2011 | 3 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 2011 | 15 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2011 | 58 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2011 | 60 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2011 | 75 | 0.030 |
Why?
|
| Nucleoproteins | 1 | 2011 | 1 | 0.030 |
Why?
|
| Rats | 1 | 2015 | 1605 | 0.020 |
Why?
|
| Plant Lectins | 1 | 2011 | 2 | 0.020 |
Why?
|
| DNA Probes | 1 | 2011 | 17 | 0.020 |
Why?
|
| Clostridium botulinum type F | 1 | 2010 | 1 | 0.020 |
Why?
|
| Viral Matrix Proteins | 1 | 2011 | 34 | 0.020 |
Why?
|
| SNARE Proteins | 1 | 2010 | 4 | 0.020 |
Why?
|
| Antibodies, Viral | 1 | 2011 | 56 | 0.020 |
Why?
|
| DNA Primers | 1 | 2011 | 87 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2010 | 5 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 2010 | 14 | 0.020 |
Why?
|
| Rabbits | 1 | 2011 | 185 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 455 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 242 | 0.020 |
Why?
|
| Lamivudine | 1 | 2009 | 1 | 0.020 |
Why?
|
| Adenine | 1 | 2009 | 15 | 0.020 |
Why?
|
| Ricinus | 1 | 2009 | 1 | 0.020 |
Why?
|
| Influenza, Human | 1 | 2011 | 122 | 0.020 |
Why?
|
| Indicator Dilution Techniques | 1 | 2009 | 1 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2009 | 17 | 0.020 |
Why?
|
| Hemagglutinins | 1 | 2009 | 3 | 0.020 |
Why?
|
| Clostridium botulinum type A | 1 | 2009 | 1 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2009 | 50 | 0.020 |
Why?
|
| Reassortant Viruses | 1 | 2009 | 1 | 0.020 |
Why?
|
| Analytic Sample Preparation Methods | 1 | 2009 | 1 | 0.020 |
Why?
|
| Serotyping | 1 | 2009 | 15 | 0.020 |
Why?
|
| Glycosylation | 1 | 2009 | 15 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2009 | 55 | 0.020 |
Why?
|
| Virulence | 1 | 2009 | 21 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2009 | 63 | 0.020 |
Why?
|
| Sweden | 1 | 2009 | 14 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2009 | 31 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2009 | 95 | 0.020 |
Why?
|
| Binding Sites | 1 | 2009 | 125 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2009 | 141 | 0.020 |
Why?
|
| Streptococcus oralis | 1 | 2008 | 1 | 0.020 |
Why?
|
| Streptococcus mitis | 1 | 2008 | 2 | 0.020 |
Why?
|
| Bacterial Typing Techniques | 1 | 2008 | 9 | 0.020 |
Why?
|
| Enterococcus faecalis | 1 | 2008 | 10 | 0.020 |
Why?
|
| Molecular Epidemiology | 1 | 2008 | 20 | 0.020 |
Why?
|
| Neutrophils | 1 | 2009 | 102 | 0.020 |
Why?
|
| Molecular Weight | 1 | 2008 | 42 | 0.020 |
Why?
|
| Streptococcus pyogenes | 1 | 2008 | 17 | 0.020 |
Why?
|
| Radioisotope Dilution Technique | 1 | 2008 | 1 | 0.020 |
Why?
|
| Proteome | 1 | 2008 | 34 | 0.020 |
Why?
|
| Staphylococcus aureus | 1 | 2008 | 45 | 0.020 |
Why?
|
| Cluster Analysis | 1 | 2008 | 129 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2008 | 83 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2007 | 11 | 0.020 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2008 | 49 | 0.020 |
Why?
|
| Antibodies | 1 | 2007 | 53 | 0.020 |
Why?
|
| Exotoxins | 1 | 2007 | 9 | 0.020 |
Why?
|
| Bacillus anthracis | 1 | 2007 | 9 | 0.020 |
Why?
|
| Travel | 1 | 2007 | 15 | 0.020 |
Why?
|
| Thyrotropin | 1 | 2006 | 9 | 0.020 |
Why?
|
| Thyroxine | 1 | 2006 | 16 | 0.020 |
Why?
|
| Mass Screening | 1 | 2009 | 225 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2009 | 153 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 152 | 0.020 |
Why?
|
| Benzofurans | 1 | 2005 | 5 | 0.020 |
Why?
|
| Mercury | 1 | 2005 | 8 | 0.020 |
Why?
|
| Metals | 1 | 2005 | 16 | 0.020 |
Why?
|
| Occupations | 1 | 2004 | 10 | 0.020 |
Why?
|
| Polymers | 1 | 2005 | 59 | 0.020 |
Why?
|
| Hydrocarbons | 1 | 2003 | 2 | 0.020 |
Why?
|
| Mutagens | 1 | 2003 | 4 | 0.020 |
Why?
|
| New York City | 1 | 2003 | 13 | 0.020 |
Why?
|
| Metals, Heavy | 1 | 2003 | 7 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2004 | 55 | 0.020 |
Why?
|
| Mothers | 1 | 2004 | 81 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2007 | 864 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2004 | 504 | 0.010 |
Why?
|
| Insect Control | 1 | 2002 | 1 | 0.010 |
Why?
|
| United States Environmental Protection Agency | 1 | 2002 | 2 | 0.010 |
Why?
|
| Geography | 1 | 2003 | 34 | 0.010 |
Why?
|
| Local Government | 1 | 2002 | 4 | 0.010 |
Why?
|
| Interinstitutional Relations | 1 | 2002 | 11 | 0.010 |
Why?
|
| State Government | 1 | 2002 | 31 | 0.010 |
Why?
|
| Data Collection | 1 | 2003 | 163 | 0.010 |
Why?
|
| Continental Population Groups | 1 | 2004 | 221 | 0.010 |
Why?
|
| Italy | 1 | 2002 | 15 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 2002 | 17 | 0.010 |
Why?
|
| Accidents, Occupational | 1 | 2002 | 15 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2007 | 1313 | 0.010 |
Why?
|
| Time Factors | 1 | 2002 | 2004 | 0.010 |
Why?
|